The Irish Pharmaceutical Healthcare Association (IPHA), which represents 47 research based pharmaceutical companies in Ireland has welcomed the publication of a report on Evaluating Orphan Drugs which has been published by the Joint Oireachtas Committee on Health.
Revised ‘drug iceberg’ report a valuable contribution to ongoing debate on how best to ensure patients have timely access to the best medicines
Dublin, 21 February 2018 – The biopharmachem sector maintained its position as the largest exporter of goods from Ireland in 2017 with record total exports of €67.8 billion, up 2% on the previous year*. The sector now accounts for 55% of overall Irish exports of goods (excluding services), the BioPharma Ambition Conference 2018 was told today.
The Irish Pharmaceutical Healthcare Association (IPHA) which represents the research based pharmaceutical industry in Ireland, has stated that it will work with initiatives that truly speed up the slow and late access to new medicines for Irish patients.
Meeting hears about unique Swedish IT-based self-care initiative, which builds a ‘flu’ map and encourages patients to visit pharmacies for prevention and treatment
The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed a call from a group of organisations representing patients, healthcare professionals and the health care industry to the EU and UK to prioritise patients in the Brexit negotiations.
The Irish Pharmaceutical Healthcare Association (IPHA), which represents 47-research based pharmaceutical companies in Ireland, has warmly welcomed the latest National Cancer Registry Annual Report.